IMMUNEONCIA Trademark

Trademark Overview


On Monday, April 22, 2024, a trademark application was filed for IMMUNEONCIA with the United States Patent and Trademark Office. The USPTO has given the IMMUNEONCIA trademark a serial number of 98513235. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, April 22, 2024. This trademark is owned by ImmuneOncia Therapeutics, Inc.. The IMMUNEONCIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; anti-cancer preparations; tumor suppressing agents; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for health care; pharmaceuticals; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatme...
immuneoncia

General Information


Serial Number98513235
Word MarkIMMUNEONCIA
Filing DateMonday, April 22, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, April 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical products for the treatment of cancer; biological preparations for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; anti-cancer preparations; tumor suppressing agents; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for health care; pharmaceuticals; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for the treatment of central nervous system (CNS) diseases; adhesive plasters; plasters

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 22, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmuneOncia Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressYongin-si, Gyeonggi-do 17084
KR

Trademark Events


Event DateEvent Description
Monday, April 22, 2024NEW APPLICATION ENTERED
Monday, April 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED